- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 58.29M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $249.96M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $249.7M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $174.9M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $145.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $178.86M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $192.28M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $466.97M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $480.81M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $794.81M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $764.53M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.28B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.25B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $26.5M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 60.76M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $5.99M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $9.36M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $687.91M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $672.44M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.37 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.39 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $24.7M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $29.64M |
| Net Income | Q1 2025 · Mar 31, 2024 | $21.85M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $22.05M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $75.42M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $99.07M |